The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions

Molecular Endocrinology

Volumn 19, Issue 5, 2005, Pages 1158-1169

  Pascual Le Tallec, Laurent ^a,d   Simone, Federico ^b   Viengchareun, Say ^a   Meduri, Geri ^c   Thirman, Michael J ^b   Lombès, Marc ^a  

^a INSERM   (France)

^b UNIVERSITY OF CHICAGO   (United States)

^c BICÊTRE HOSPITAL   (France)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ELONGATION FACTOR; ELONGATION FACTOR ELL; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MINERALOCORTICOID RECEPTOR; MIXED LINEAGE LEUKEMIA PROTEIN; MUTANT PROTEIN; PROGESTERONE RECEPTOR; REGULATOR PROTEIN; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; PEPTIDE ELONGATION FACTORS; PROTO-ONCOGENES; RECEPTORS, MINERALOCORTICOID; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 17844395675     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0331     Document Type: Article

References (45)

1. Nuclear Receptor Nomenclature Committee 1999 A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163
2. Beato M, Sanchez-Pacheco A 1996 Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17:587-609
3. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
4. Bonvalet JP 1998 Regulation of sodium transport by steroid hormones. Kidney Int Suppl 65:S49-S56
5. Pearce D, Bhargava A, Cole TJ 2003 Aldosterone: its receptor, target genes, and actions. Vitam Horm 66:29-76
6. Young MJ, Funder JW 2002 Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J Hypertens 20:1465-1468
7. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
8. Bhargava A, Pearce D 2004 Mechanisms of mineralocorticoid action: determinants of receptor specificity and actions of regulated gene products. Trends Endocrinol Metab 15:147-153
9. Funder JW, Pearce PT, Smith R, Smith AI 1988 Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585
10. Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192
11. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin ME 1994 The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840
12. Couette B, Fagart J, Jalaguier S, Lombes M, Souque A, Rafestin-Oblin ME 1996 Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure. Biochem J 315:421-427
13. Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744
14. Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Mol Endocrinol 14:1210-1221
15. Fuse H, Kitagawa H, Kato S 2000 Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol Endocrinol 14:889-899
16. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T, Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol Cell Biol 22:3698-3706
17. Pascual-Le Tallec L, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, Lombes M 2003 PIAS1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity-implication of SUMO-1 modification. Mol Endocrinol 17:2529-2542
18. Obradovic D, Tirard M, Nemethy Z, Hirsch O, Gronemeyer H, Almeida OF 2004 DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors? Mol Pharmacol 65:761-769
19. McEwan IJ, Wright AP, Dahlman-Wright K, Carlstedt-Duke J, Gustafsson JA 1993 Direct interaction of the τ 1 transactivation domain of the human glucocorticoid receptor with the basal transcriptional machinery. Mol Cell Biol 13:399-407
20. Shilatifard A 1998 Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J 12:1437-1446
21. Deppe CE, Heering PJ, Viengchareun S, Grabensee B, Farman N, Lombes M 2002 Cyclosporine a and FK506 inhibit transcriptional activity of the human mineratocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 143:1932-1941
22. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombes M 2001 A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 15:1586-1598
23. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736
24. Le Menuet D, Viengchareun S, Muffat-Joly M, Zennaro MC, Lombes M 2004 Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models. Mol Cell Endocrinol 217:127-136
25. Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD, Montminy M 1997 RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90:1107-1112
26. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
27. Lin DY, Fang HI, Ma AH, Huang YS, Pu YS, Jenster G, Kung HJ, Shin HM 2004 Negative modulation of androgen receptor transcriptional activity by Daxx. Mol Cell Biol 24:10529-10541
28. Shilatifard A, Haque D, Conaway RC, Conaway JW 1997 Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex. J Biol Chem 272:22355-22363
29. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ, Yamamoto KR 2003 Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci USA 100:13845-13850
30. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD 1994 Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 91:12110-12114
31. Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ 2001 The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol 21:5678-5687
32. Lavau C, Luo RT, Du C, Thirman MJ 2000 Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci USA 97:10984-10989
33. Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ 2003 ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 101:2355-2362
34. Wiederschain D, Kawai H, Gu J, Shilatifard A, Yuan ZM 2003 Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. Mol Cell Biol 23:4230-4246
35. Johnstone RW, Gerber M, Landewe T, Tollefson A, Wold WS, Shilatifard A 2001 Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival. Mol Cell Biol 21:1672-1681
36. Thirman MJ, Diskin EB, Bin SS, Ip HS, Miller JM, Simon MC 1997 Developmental analysis and subcellular localization of the murine homologue of ELL. Proc Natl Acad Sci USA 94:1408-1413
37. Eissenberg JC, Ma J, Gerber MA, Christensen A, Kennison JA, Shilatifard A 2002 dELL is an essential RNA polymerase II elongation factor with a general role in development. Proc Natl Acad Sci USA 99:9894-9899
38. Sakurai K, Michiue T, Kikuchi A, Asashima M 2004 Inhibition of the Canonical Wnt signaling pathway in cytoplasm: a novel property of the carboxyl terminal domains of two Xenopus ELL genes. Zool Sci 21:407-416
39. Miller T, Williams K, Johnstone RW, Shilatifard A 2000 Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3. J Biol Chem 275:32052-32056
40. Planey SL, Derfoul A, Steplewski A, Robertson NM, Litwack G 2002 Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J Biol Chem 277:42188-42196
41. Almeida OF, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH, Meyer M, Holsboer F, Michaelidis TM 2000 Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 14:779-790
42. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
43. Polak PE, Simone F, Kaberlein JJ, Luo RT, Thirman MJ 2003 ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia. Mol Biol Cell 14:1517-1528
44. Vandewalle A, Lelongt B, Geniteau-Legendre M, Baudouin B, Antoine M, Estrade S, Chatelet F, Verroust P, Cassingena R, Ronco P 1989 Maintenance of proximal and distal cell functions in SV40-transformed tubular cell lines derived from rabbit kidney cortex. J Cell Physiol 141:203-221
45. Binart N, Lombes M, Rafestin-Oblin ME, Baulieu EE 1991 Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system. Proc Natl Acad Sci USA 88:10681-10685